Bicycle Therapeutics (BCYC) Accounts Payables (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Accounts Payables data on file, last reported at $6.0 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 46.25% year-over-year to $6.0 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (down 46.25% YoY), and the FY2025 full-year result was $9.7 million, down 38.78% from the prior year.
• Accounts Payables for Q1 2026 stood at $6.0 million, down from $9.7 million in the prior quarter.
• Across five years, Accounts Payables topped out at $18.3 million in Q2 2025 and bottomed at $2.8 million in Q1 2023.
• The 5-year median for Accounts Payables is $7.1 million (2024), against an average of $8.6 million.
• The widest annual swing landed in 2022, when Accounts Payables soared 301.51%; it then sank 46.25% in 2026.
• A 5-year view of Accounts Payables shows it stood at $6.5 million in 2022, then soared by 101.64% to $13.0 million in 2023, then grew by 21.02% to $15.8 million in 2024, then tumbled by 38.78% to $9.7 million in 2025, then sank by 38.26% to $6.0 million in 2026.
• The last three Accounts Payables figures came in at $6.0 million (Q1 2026), $9.7 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.

Peer Comparison